The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Atorvastatin Centrient 20 mg film-coated tablets

20 milligram(s) Film-coated tablet

DSM Sinochem Pharmaceuticals Netherlands B.V.PA1832/005/002

Main Information

Trade NameAtorvastatin Centrient 20 mg film-coated tablets
Active SubstancesAtorvastatin
Strength20 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderDSM Sinochem Pharmaceuticals Netherlands B.V.
Licence NumberPA1832/005/002

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA05 atorvastatin

Status

Authorised/WithdrawnAuthorised
Licence Issued20/10/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0001-003-003
Interchangeable List DocumentPDF of Interchangeable List
« Back